🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

National HealthCare Corporation NHC R2K

Healthcare · Medical Care Facilities · United States
https://www.nhccare.com
Company Profile ↓
$210.79
+107.83% 1Y
Mkt Cap$3.29B
P/E26.78
P/B2.83
Div. Yield1.31%
52W High$218.44
52W Low$92.88
Book Value$69.90
EPS (TTM)$7.87

Company Overview

National HealthCare Corporation engages in the operation of services to skilled nursing facilities, assisted and independent living facilities, homecare and hospice agencies, and health hospitals. It operates through two segments: Inpatient and Homecare and Hospice Services. The company's skilled nursing facilities offer licensed therapy services, nutrition services, social services, activities, and housekeeping and laundry services, as well as medical services prescribed by physicians; and rehabilitative services, such as physical, speech, respiratory, and occupational therapy for patients recovering from strokes, heart attacks, orthopedic conditions, neurological illnesses, or other illnesses, injuries, or disabilities. It provides medical specialty units comprise memory care units and sub-acute nursing units that provide specialized care and programs for persons with Alzheimer's or related disorders; and assisted living facilities offer personal care services and assistance with general activities of daily living, such as dressing, bathing, meal preparation, and medication management. Its independent living facilities offers specially designed residential units for the active and ambulatory elderly and provide various ancillary services for residents, including restaurants, activity rooms and social areas; and behavioral health services to both adults and geriatric patients with psychiatric, emotional, and addictive disorders. In addition, the company homecare agencies assist those who wish to stay at home or in assisted living residences but still require some degree of medical care or assistance with daily activities; hospice agencies that provides hospice and palliative care; and operates pharmacies, as well as managed care insurance solutions. Further, the company offers management, accounting, and financial services; and leases its properties to third party operators. The company was founded in 1971 and is based in Murfreesboro, Tennessee.

Why Investors Should Care

Positive Free Cash Flow

Generates positive free cash flow, funding growth and shareholder returns internally.

Recent Developments

  • Dec 2025 Revenue of $1.52B (+16.1% YoY); net profit $120.02M.
  • Trailing 12 Months Year-on-year growth — revenue +2.2%, earnings +9.7%.
  • 5-Year Trend Long-term compounding — revenue CAGR 5.7%, profit CAGR 5.6%.

Growth & Price Performance

Compounded Sales Growth

5 Years:5.67%
1 Year:2.20%

Compounded Profit Growth

5 Years:5.64%
1 Year:9.70%

Stock Price Performance

1 Year:+107.83%
6 Months:+63.62%
3 Months:+24.69%
1 Month:+7.92%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bullish
52-Week Range 94% of range
$92.88 $218.44
Trend Signals
  • Price vs 50-DMAAbove
  • Price vs 200-DMAAbove
  • RSI (14)58.96 · Neutral
Price Performance
1M+7.92%
3M+24.69%
6M+63.62%
1Y+107.83%
Valuation vs Sector

P/E of 26.78 is above the sector median of 25.41 — pricier than peers.

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Generates positive free cash flow.
  • In a confirmed uptrend (50-DMA above 200-DMA).

CONS

No notable concerns flagged.

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
26.78
Industry PE
25.41
Forward P/E
490.21
PEG Ratio
0.82
Book Value
$69.90
Price to Book
2.83
P/S
2.02
EV/EBITDA
16.39
Dividend Yield
1.31%

Growth (CAGR)

Revenue 5Y
5.67%
Profit 5Y
5.64%
Revenue (YoY)
2.20%
Earnings (YoY)
9.70%

Profitability & Returns

ROCE
10.08%
ROE
12.01%
ROA
5.28%
Profit Margin
8.10%
Op Margin
8.45%
Gross Margin
39.18%
EPS (Latest Qtr)
$2.27
EPS (TTM)
$7.87

Balance Sheet & Liquidity

Debt/Equity
3.58
Quick Ratio
1.58
Current Ratio
1.86
Debt
$39.31M
Total Assets
$1.52B
Current Assets
-
Working Capital
-

Ownership

Promoter Holding
18.93%
Chg in Prom Hold
-0.00%
FII / Inst Holding
67.47%
Chg in FII Hold
0.03%

Financial Snapshot

Enterprise Value
$3.29B
Total Revenue (TTM)
$1.53B
EBITDA
$175.39M
Free Cash Flow
$118.57M
Operating Cash Flow
$208.36M
Shares Outstanding
15.62M
Gross Margin
39.18%
Payout Ratio
32.53%

Peer comparison

Peer companies in the same sector (Healthcare).

#NameCMP $P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 NHC National HealthCare Corporation R2K 210.79 26.78 $3.29B 1.31% 10.08% 12.01% 5.67% 5.64%
2 LLY Eli Lilly and Company SPX 1,152.54 41.02 $1.03T 0.61% - 107.46% 7.20% 11.41%
3 JNJ Johnson & Johnson SPX 253.85 29.45 $611.07B 2.23% 14.88% 26.42% 2.43% 4.76%
4 ABBV AbbVie Inc. SPX 244.78 119.40 $432.48B 3.04% 10.47% -129.24% 1.75% -29.06%
5 UNH UnitedHealth Group Incorporated SPX 425.19 32.02 $386.13B 2.27% 9.74% 12.18% 10.40% 5.43%
6 MRK Merck & Co., Inc. SPX 120.78 34.02 $298.31B 2.86% - 18.94% 5.64% 10.01%
7 AZN AstraZeneca PLC NDX 164.50 24.81 $255.12B 1.77% 15.97% 23.48% 9.82% 45.96%
8 TMO Thermo Fisher Scientific Inc. SPX 534.07 29.33 $198.47B 0.40% 8.14% 13.52% 8.81% 12.95%
9 AMGN Amgen Inc. NDXSPX 355.25 24.69 $191.73B 2.84% 18.02% 101.32% 11.77% 5.58%
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric Dec 2014Mar 2015Jun 2015Sep 2015Dec 2015Mar 2016Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020Sep 2020Mar 2021Jun 2021Sep 2021Mar 2022Jun 2022Sep 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025Mar 2026
Revenue ---------238.54M238.69M241.20M246.31M242.96M242.14M246.33M248.92M248.28M247.15M247.07M253.88M256.12M261.64M250.63M250.97M263.16M276.74M278.98M271.36M270.84M269.56M282.58M288.49M297.18M300.66M340.20M373.70M374.91M382.66M381.82M
Operating Income 20.20M17.44M15.71M13.76M20.22M17.62M14.64M10.59M17.69M15.86M12.14M9.79M16.32M15.88M12.16M10.83M17.19M15.78M10.19M6.57M16.50M15.80M12.55M7.02M15.22M13.79M12.76M14.22M4.55M4.08M10.01M13.98M13.03M15.68M22.52M22.79M30.77M34.09M30.38M32.25M
Net Income 14.80M13.24M12.36M12.57M14.98M13.70M11.87M11.11M13.86M12.73M10.65M11.35M--2.79M22.46M21.14M-21.27M13.71M19.46M--26.85M28.32M12.85M21.27M104.88M-3.35M15.32M3.20M-2.43M11.72M16.28M10.39M26.21M26.84M42.79M32.20M23.72M39.24M35.86M
Diluted EPS 0.880.770.710.720.990.910.780.730.910.840.700.751.41-0.181.471.391.191.390.891.270.89-1.761.840.841.386.80-0.220.990.21-0.160.761.060.681.691.732.732.071.522.502.27

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue ------923.58M963.89M980.35M996.38M1.03B1.07B1.09B1.14B1.31B1.52B
Operating Income 57.63M78.85M68.24M72.08M68.01M67.13M60.54M54.11M56.08M49.04M48.16M50.92M31.90M57.46M89.89M128.35M
Net Income 52.70M64.99M59.30M64.61M53.37M53.14M50.54M56.20M58.96M68.21M41.87M138.59M22.45M66.80M101.93M120.02M
Diluted EPS 3.223.963.573.873.143.203.323.693.874.442.728.991.454.346.537.67

Balance Sheet (Annual)

Figures in USD.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Sep 2024Dec 2024Dec 2025
Total Assets --870.42M924.70M984.36M1.07B1.05B1.09B1.10B1.08B1.29B1.36B1.40B1.28B1.31B-1.52B1.53B
Total Equity 525.78M555.36M606.87M656.15M688.11M734.15M631.00M669.61M702.74M733.28M778.59M795.18M903.00M874.28M908.75M-980.16M1.07B
Cash & Equivalents 39.02M28.48M61.01M66.70M81.70M69.77M38.21M26.34M59.12M43.25M50.33M147.09M107.61M58.67M107.08M-76.12M92.83M
Long Term Debt --10.00M10.00M10.00M10.00M120.00M120.00M100.00M55.00M0---0129.50M129.50M32.50M
Total Liabilities -------417.84M393.09M346.49M507.58M563.87M494.94M397.94M400.32M-541.27M451.90M
Current Liabilities --220.66M228.76M167.76M183.56M150.66M150.93M155.06M157.92M194.76M281.23M263.20M197.89M214.48M-234.80M253.63M

Cash Flows (Annual)

Figures in USD.

Metric Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow 63.36M82.36M64.37M102.35M75.69M83.36M90.88M94.47M98.44M100.10M203.26M62.39M8.74M111.22M107.30M185.08M
Investing Cash Flow -46.35M-31.75M-31.23M-56.30M-57.51M-72.78M-81.48M-9.56M-33.66M-14.27M-63.88M-65.89M-5.98M-17.57M-236.69M-33.86M
Financing Cash Flow -27.55M-18.08M-27.45M-31.04M-30.12M-41.67M-27.13M-49.07M-77.27M-79.75M-41.89M-35.26M-47.64M-42.55M100.34M-135.96M
Capital Expenditure -32.29M-23.37M-22.00M-43.44M-53.30M-58.42M-62.60M-32.35M-29.77M-26.40M-21.87M-39.40M-30.20M-27.90M-27.60M-36.45M
Free Cash Flow 31.07M58.99M42.37M58.91M22.40M24.94M28.28M62.12M68.66M73.70M181.39M23.00M-21.46M83.31M79.70M148.63M
Share Buybacks 5.94M--4.70M7.00M-8.20M0867.00K872.00K53.00K836.00K9.90M2.48M13.50M14.73M

Ratios (Annual)

Figures in %.

Metric Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % ----------------
Operating Margin % ------6.6%5.6%5.7%4.9%4.7%4.7%2.9%5.0%6.9%8.5%
Net Margin % ------5.5%5.8%6.0%6.8%4.1%12.9%2.1%5.9%7.8%7.9%
ROE % 9.5%10.7%9.0%9.4%7.3%8.4%7.5%8.0%8.0%8.8%5.3%15.3%2.6%7.4%10.4%11.2%
ROCE % -12.1%9.8%8.8%7.6%7.5%6.5%5.7%6.1%4.5%4.5%4.5%3.0%5.2%7.0%10.1%

Shareholding Pattern

Insiders
18.93%
Institutions
67.47%
Public Float
83.22%

Top Institutional Holders

#Holder% HeldSharesValue
1 Blackrock Inc. 12.13% 1.90M $417.14M
2 Morgan Stanley Institutional Investment Advisors LLC 6.65% 1.04M $228.64M
3 Dimensional Fund Advisors LP 6.06% 946.98K $208.43M
4 Vanguard Portfolio Management LLC 5.05% 789.42K $173.75M
5 Vanguard Capital Management LLC 3.52% 549.55K $120.96M
6 First Trust Advisors LP 3.40% 530.30K $116.72M
7 State Street Corporation 3.15% 491.57K $108.20M
8 M Holdings Securities, Inc. 2.96% 462.41K $101.78M
9 Pacer Advisors, Inc. 2.54% 397.41K $87.47M
10 Renaissance Technologies, LLC 2.15% 335.52K $73.85M

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for NHC

Google News Wed, 01 Jul 2026

NHC buys 35 senior-care facilities for $560M from NHI - Stock Titan

<a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxObTVpaWIwZUxVcDdMZjBDQUFpbGgtXzVZWE1pRTRnRHJNLU1SRzhndVo0ZnZ6Q3FwcXZkd1ByMzRaZ0RpY3FrX0dEQkFNZHFaNWt2bjFJUkgtV0lWLXZFMWdIZGZjQUVxX3pFY0g2VVNhX0NtSVBJbzgtRl9VZ0x6bnhGUGNpNk1lMlJBWU…

Google News Fri, 10 Jul 2026

How Index Additions and New Debt Shape National HealthCare’s (NHC) Evolving Investment Narrative - Sahm

<a href="https://news.google.com/rss/articles/CBMi3gFBVV95cUxOdTRSYmJ0YmNLZjhzZFh3d0c4ZkFhc3lFQ25Kb1FtWUNrS09VYlAzSXhXeWpVMGJKbDhuSnJsOXgyYkk2WkV4c2tuZVlpMDJSQkRVUUFnSF9uNEMwbW9naElyUnZRYjlrWHFVVmQ0WEtxeDNHZG94N1dKX0VJbURtc3V3YTlwbDZzSzlOVj…

Google News Wed, 01 Jul 2026

NATIONAL HEALTHCARE CORP (NHC) Stock Chart - ChartMill

<a href="https://news.google.com/rss/articles/CBMiY0FVX3lxTE5XU3BzZnoyRjQ0X2o5SDd2VTB4R3o5Zkxvb2FjX2R5ZGNZV3dPTThpdDhfY2FzSmNnbTBBV2JCY2xsY3JsM05JVDFMdF9tQ3lEYTJwSnVFRHRYUFRRNmZ1Y05saw?oc=5" target="_blank">NATIONAL HEALTHCARE CORP (NHC) St…

Google News Sun, 03 May 2026

Is National HealthCare Corporation (NHC) A Good Stock To Buy Now? - Yahoo Finance

<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxOOEFwYVppWGlHN25UMlJuSHZtX2ZrSnJROE5vbVdBak1NM29MVWxKSWJrY1Bsd1RoQnYxQXNMQXp5c2dLU0FWaEFTT05qQWRtdU5hdFo0Z2VvWEM3Y2ozVGdzMzBWQ2lwaW5jVGRxUFF3REIzWm5WeEhscGp6T0h5VW9sZ0Y2ZXZkUURyUn…

Google News ue, 14 Jul 2026

New Hope Corporation (ASX:NHC) Gains 2.3% — Coal and Energy Stocks Ride the Oil-Driven Sector Surge - Kalkine

<a href="https://news.google.com/rss/articles/CBMixgFBVV95cUxPY1Z6SGRCZzk0cHpFMG9KNHNndDhiZmlZRURRTWU1NTZpNzE3WkMyZXFfY2xJLXV1VHRWdUJzaHdmcS1wZ1g4ekxyMENtUjNqdmZzM1BFU0ZxUE1FUG0tam91YTZxV0dZZ1ZkOWdOc3RsRlBnQkJoSkhKcXpXRFVUeUJkRnhJbmlnc0wzRU…

Google News hu, 09 Jul 2026

Technical Reactions to NHC Trends in Macro Strategies - Stock Traders Daily

<a href="https://news.google.com/rss/articles/CBMizgFBVV95cUxORkhSc01vYXBMYjdqU1l3bjFsQ2V1YV9SYkRURm9ZNzBiOHdmc01BaENVT0RmVmhULWdfcXMzUG0tT2VYU1JkSTJiMERjNjMzdU80a05SeEJ6SlFvY0N3cmpyWFh5NlNFdmRkNU9IRV9ONVRZR1ZULTVOc3NLVm1NazZuVVFVOEJwaTZabF…

NHC — Frequently Asked Questions

What is the current share price of National HealthCare Corporation (NHC)?

As of 2026-07-14 21:23 PDT, National HealthCare Corporation (NHC) trades at $210.79 on NYSE American. Its 52-week range is $92.88 to $218.44.

What is the market capitalisation of NHC?

National HealthCare Corporation (NHC) has a market capitalisation of $3.29B on NYSE American.

What is the P/E ratio of NHC?

NHC trades at a trailing price-to-earnings (P/E) ratio of 26.78. The industry average P/E is 25.41. Its price-to-book (P/B) ratio is 2.83.

Does NHC pay a dividend?

National HealthCare Corporation (NHC) currently offers a dividend yield of 1.31%.

What is the return on equity (ROE) of NHC?

NHC has a return on equity (ROE) of 12.01%. Its return on capital employed (ROCE) is 10.08%.

Is NHC a good stock to buy?

This page provides a data-driven analysis of National HealthCare Corporation (NHC), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks
⚙Ad space